Evidence map›Paper›PMID 26346833›Full record

ArticleMolecular biotechnology2015

Potato Virus M-Like Nanoparticles: Construction and Characterization.

Ieva Kalnciema, Ina Balke, Dace Skrastina, Velta Ose, Andris Zeltins

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ieva KalnciemaLatvian Biomedical Research and Study Centre, Ratsupites 1, Riga, 1067, Latvia. kalnciema@biomed.lu.lv.
Ina BalkeLatvian Biomedical Research and Study Centre, Ratsupites 1, Riga, 1067, Latvia. inab@biomed.lu.lv.
Dace SkrastinaLatvian Biomedical Research and Study Centre, Ratsupites 1, Riga, 1067, Latvia. daceskr@biomed.lu.lv.
Velta OseLatvian Biomedical Research and Study Centre, Ratsupites 1, Riga, 1067, Latvia. velta@biomed.lu.lv.
Andris ZeltinsLatvian Biomedical Research and Study Centre, Ratsupites 1, Riga, 1067, Latvia. anze@biomed.lu.lv.
Latvian Biomedical Research and Study Centre · LV

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Virus-like particles (VLPs) are multisubunit self-assembly competent protein structures with identical or highly related overall structure to their corresponding native viruses. To construct a new filamentous VLP carrier, the coat protein (CP) gene from potato virus M (PVM) was amplified from infected potato plants, cloned, and expressed in Escherichia coli cells. As demonstrated by electron microscopy analysis, the PVM CP self-assembles into filamentous PVM-like particles, which are mostly 100-300 nm in length. Adding short Gly-Ser peptide at the C-terminus of the PVM, CP formed short VLPs, whereas peptide and protein A Z-domain fusions at the CP N-terminus retained its ability to form typical PVM VLPs. The PVM-derived VLP carrier accommodates up to 78 amino acid-long foreign sequences on its surface and can be produced in technologically significant amounts. PVM-like particles are stable at physiological conditions and also, apparently do not become disassembled in high salt and high pH solutions as well as in the presence of EDTA or reducing agents. Despite partial proteolytic processing of doubled Z-domain fused to PVM VLPs, the rabbit IgGs specifically bind to the particles, which demonstrates the functional activity and surface location of the Z-domain in the PVM VLP structure. Therefore, PVM VLPs may be recognized as powerful structural blocks for new human-made nanomaterials.

Indexed as

Genome, ViralAnimalsCarlavirusCloning, MolecularDNA, ComplementaryEscherichia coliHydrogen-Ion ConcentrationImmunoglobulin GNanoparticlesRabbitsSolanum tuberosumSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationVaccines, Virus-Like ParticleVirus AssemblyDNA, ComplementaryImmunoglobulin GVaccines, Virus-Like ParticleCarlavirusPlantProtein AVirus-like

Identifiers

PMID26346833
OpenAlexW1565558431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.